About this trial
This study is to evaluate differences in the gut and follicle/scalp microbiome signature in AGA compared to a non-AGA population. Also, to investigate differences in inflammation and other biomarkers in AGA compared to non-AGA population at baseline and after a successful treatment
Eligibility criteria
Qualifiers
Male volunteer from 21 to 45 years old
Volunteer with BMI between 18.5 to 30 kg/m2
Volunteer willing and able to fulfill the study requirements and schedule
Volunteer willing to give their stool sample, as well as swabs, follicles, and blood.
Disqualifiers
Volunteer with severe gastro-intestinal symptoms (including gluten and lactose intolerance)
Volunteer with auto-immune disease, diabetes; hyper or hypo-thyroidism ; chronic kidney failure
Volunteer with diagnosis of scalp-related disease such as folliculitis, lichen planopilaris, folliculitis decalvans, tinea capitis, head lice, or seborrheic dermatitis
Volunteer undergoing hypertension treatment
Trial design
Treatments tested in this trial
- Not listed